Cooley

Asia

Highly specialized global team advising clients on the full range of legal matters across Asia and the Pacific Rim

Zero2IPO Names Cooley Legal Advisor of the Year for VC/PE in China

Learn More

EpimAb + Innovent Enter $120 Million Bispecific Antibody Partnership

Learn More

FibroGen Closes Largest Biotech IPO in 12 Years

Learn More

Johnson Controls Joint Venture Named a Deal of the Year by China Business Law Journal

Learn More

Regularly advise Asia based clients on unique business opportunities and legal challenges across China, Japan, India, Taiwan, Korea, Vietnam, Australia and New Zealand
Highly specialized multi-lingual team, including multiple lawyers advising clients on a full range of formation and operational matters across Asia and the Pacific Rim region
Consistently ranks #1 in the global BioPharm Insight Licensing League Tables for global biotechnology and earns top recognition for Asia-Pacific pharmaceutical partnering and licensing transactions
Established in Shanghai since 2011
Built 100+ venture capital and private equity funds in China over 25 years and advised on 40+ India specific funds since 1995
Network of relationships with leading law, accounting and venture capital firms across the region

Christina Zhang Partner-in-Charge - Shanghai

James Lu Partner, Shanghai

Patrick Loofbourrow Partner, Shanghai

Pang Lee Partner, Shanghai

Jordan Silber Partner, San Francisco

Lila Hope Partner, Palo Alto

Julie Wicklund Special Counsel, Palo Alto

ViewHide related contacts

ViewHide related news

ViewHide related events